{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:37:55Z","timestamp":1793039875695,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jmii.2020.08.015","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:24:29Z","timestamp":1597926269000},"page":"1028-1037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics"],"prefix":"10.1016","volume":"54","author":[{"given":"Yusuke","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sakanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arufumi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-9365","authenticated-orcid":false,"given":"Kenta","family":"Murotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2020.08.015_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc2917","article-title":"Severe sepsis epidemiology: sampling, selection, and society","volume":"8","author":"Linde-Zwirble","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2020.08.015_bib2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/01.CCM.0000261890.41311.E9","article-title":"Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003","volume":"35","author":"Dombrovskiy","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for the management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","article-title":"Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis","volume":"34","author":"Uzzan","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib5","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"Pierrakos","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2020.08.015_bib6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","article-title":"A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia","volume":"125","author":"Micek","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2020.08.015_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2020.08.015_bib8","first-page":"CD007498","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"10","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmii.2020.08.015_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2020.08.015_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","article-title":"Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use","volume":"57","author":"Schuetz","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib11","first-page":"59","article-title":"Clinical utility and measurement of procalcitonin","volume":"38","author":"Samsudin","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jmii.2020.08.015_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10238-012-0191-8","article-title":"Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis","volume":"13","author":"Brodsk\u00e1","year":"2013","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajem.2016.12.017","article-title":"Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria","volume":"35","author":"Yan","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.21037\/atm.2019.03.24","article-title":"Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection","volume":"7","author":"Leng","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2020.08.015_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/cc306","article-title":"Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS","volume":"3","author":"Meisner","year":"1999","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2020.08.015_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22996","article-title":"Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3","author":"Jekarl","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jmii.2020.08.015_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:26:46Z","timestamp":1761658006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118220302139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1684118220302139"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2020.08.015","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2020.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}